Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

25 Jan 2011 07:00

RNS Number : 9982Z
Avon Rubber PLC
25 January 2011
 



Strictly embargoed until 07:00 Tuesday 25 January 2011

AVON RUBBER p.l.c.

("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 OCTOBER 2010 to 24 JANUARY 2011

The Group has maintained the progress reported in the 2010 year-end announcement in the first quarter of our 2011 financial year, showing an improved financial performance over the comparative period last year.

Protection & Defence

We have continued to deliver mask systems and spare filters on schedule to the US DoD. In the period we also delivered masks with a sales value of $3.1m under our first Foreign Military Sales ('FMS') order and received a further significant order from Saudi Arabia for delivery later in the financial year. All of our US government related businesses have experienced some delays in the release of funds ahead of the approval of the 2010/2011 budget, but we expect to see this resolved during the second quarter of our financial year. Despite this we have seen an improved level of activity in the US homeland security market and our fire protection business ISI performed ahead of the corresponding period last year.

AEF continues to be profitable.

The UK MoD has exercised the third and final option of its three year contract for the supply of S10 masks as expected. This has a sales value of £1.55m and these masks are for delivery in our 2011 financial year.

Dairy

The market for our Dairy products has remained robust during the period under review. Our revenues are significantly up on the same period last year and despite higher input costs, an improved operational cost base and efficiencies have allowed us to continue to enhance our operating margins.

Net debt and interest payable

Net debt was £12.9m at 31 December 2010 (30 September 2010: £12.6m). The Group's new banking facilities which came into effect on 1 October 2010 have led to a reduction in the interest cost against the same period last year.

Outlook

We remain on track to deliver growth and improved results for the 2011 financial year, although the timing of the release of US Government funding may shift certain deliveries from the Protection & Defence business into the second half of the year.

 

In our Dairy business we expect the positive performance achieved so far to be continued.

 

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Hayley Baddon, Corporate Communications

01225 896363

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Clare Thomas

020 7067 0700

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological,

Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder,

emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced

CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised

solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and

tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSEAFWLFFSESF
Date   Source Headline
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR
8th Jul 202412:00 pmRNSDirectors'/PDMR Shareholdings
6th Jun 20243:00 pmRNSDirectors'/PDMR Shareholdings
30th May 20245:00 pmRNSHolding(s) in Company
28th May 20245:00 pmRNSHolding(s) in Company
24th May 20244:00 pmRNSHolding(s) in Company
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.